BeStock  
Markets › Compare › JAZZ vs BNTX

JAZZ vs BNTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
JAZZ · Jazz Pharmaceuticals$230.26 ▼ 2.62%
BNTX · BioNTech$80.96 ▼ 0.52%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8097114131148Nov 24, '25May 26, '26Nov 20, '26
  • JAZZ +27.3%
  • BNTX -16.1%

Head to head

MetricJAZZBNTX
Price$230.26$80.96
Change today▼ 2.62%▼ 0.52%
Market cap$14.78B$20.07B
Return, 3 months-9.5%-28.2%
Return, year to date+35.4%-15.0%
Return, 1 year+30.1%-15.3%
P/E (TTM)68.1–
P/B3.51.0
P/E percentile vs own 5y88th44th
Dividend yield––
Revenue growth (YoY, latest qtr)+10.4%-15.1%
Net profit growth (YoY)-292.3%+742.9%
Gross margin89.1%75.0%
Operating margin24.0%-72.7%
Net margin4.4%-60.9%
Return on equity5.1%-8.1%
Analyst target vs. price+33.4%+47.4%
Analyst buy share100%75%
RSI (14)4931
30-day volatility41.4%35.9%
Max drawdown, 1 year-21.6%-32.2%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BNTX is the largest of the group by market value.
  • JAZZ has returned the most over the past year.
  • JAZZ is growing revenue fastest.
  • JAZZ keeps the most profit per dollar of sales.
  • BNTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top